Ambrx Biopharma Inc ADR (AMAM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 06-2021 | 12-2020 | 12-2019 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 170,906 | 168,032 | 91,278 | 16,263 |
| Receivables | 1,239 | 746 | 428 | 843 |
| Other current assets | 4,661 | 4,251 | 1,371 | 1,051 |
| TOTAL | $176,806 | $173,029 | $93,077 | $18,157 |
| Non-Current Assets | ||||
| PPE Net | 7,850 | 5,524 | 5,166 | 5,159 |
| Other Non-Current Assets | 36,492 | 37,739 | 37,453 | 38,599 |
| TOTAL | $44,342 | $43,263 | $42,619 | $43,758 |
| Total Assets | $229,019 | $213,725 | $134,021 | $61,727 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 5,272 | 3,768 | 2,820 | 5,390 |
| Accrued Expenses | 14,125 | 7,732 | 2,375 | 3,885 |
| Other current liabilities | 4,267 | 4,314 | 6,470 | 4,214 |
| TOTAL | $24,579 | $17,484 | $13,260 | $14,942 |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 0 | 67 | 1,425 | 2,563 |
| TOTAL | $2,261 | $2,704 | $5,566 | $10,168 |
| Total Liabilities | $39,052 | $20,928 | $20,424 | $28,303 |
| Shareholders' Equity | ||||
| Common Shares | 27 | 24 | 0 | 14 |
| Retained earnings | -213,632 | -174,563 | -145,553 | -129,010 |
| Other shareholders' equity | -790 | -790 | 252,345 | -843 |
| TOTAL | $189,967 | $192,797 | $113,597 | $33,424 |
| Total Liabilities And Equity | $229,019 | $213,725 | $134,021 | $61,727 |